ConductScience.org, home

Paper28480899

Immunosuppressive cell death in cancer.

Hou J and 2 others. Nat Rev Immunol, 2017. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Immunosuppressive cell death in cancer. Papers, record 28480899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28480899

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunosuppressive cell death in cancer.
PubMed
Journal
Nat Rev Immunol
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Comment
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.67
iCite
Revised in PubMed
2025-05-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hou JJiajie
2Greten TFTim F
3Xia QQiang

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Communicable DiseasesMajor topic
NeoplasmsMajor topic
Cell Death
Humans
Immunosuppressive Agents

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Z99 CA999999Intramural NIH HHSUnited StatesZ99CA999999PubMedNIH RePORTER
ZIABC011343NIHNIH RePORTER

Download CSV of grants

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in28480896Reply: Immunosuppressive cell death in cancer.https://conductscience.org/library/papers/28480896PubMed
Comment on27748397Immunogenic cell death in cancer and infectious disease.https://conductscience.org/library/papers/27748397PubMed

Download CSV of comments and corrections

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124746841MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study.Lancet Oncol2014https://conductscience.org/library/papers/24746841PubMed
226343536CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation.Nat Immunol2015https://conductscience.org/library/papers/26343536PubMed
325681553Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9.J Hepatol2015https://conductscience.org/library/papers/25681553PubMed
427828943Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.Nature2016https://conductscience.org/library/papers/27828943PubMed
525822788IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.Nature2015https://conductscience.org/library/papers/25822788PubMed
627434011Interleukin 1α and the inflammatory process.Nat Immunol2016https://conductscience.org/library/papers/27434011PubMed
721992733The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review.Future Oncol2011https://conductscience.org/library/papers/21992733PubMed
827748397Immunogenic cell death in cancer and infectious disease.Nat Rev Immunol2017https://conductscience.org/library/papers/27748397PubMed
922770218A CXCL1 paracrine network links cancer chemoresistance and metastasis.Cell2012https://conductscience.org/library/papers/22770218PubMed
1027049944The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.Nature2016https://conductscience.org/library/papers/27049944PubMed
1125344738Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.Nat Med2014https://conductscience.org/library/papers/25344738PubMed
1217128264Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis.Nat Cell Biol2006https://conductscience.org/library/papers/17128264PubMed
1323723299HMGB1 in cancer: good, bad, or both?Clin Cancer Res2013https://conductscience.org/library/papers/23723299PubMed
1427626381Ionic immune suppression within the tumour microenvironment limits T cell effector function.Nature2016https://conductscience.org/library/papers/27626381PubMed
1525924065Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.Nature2015https://conductscience.org/library/papers/25924065PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42165001Sequential nanocatalytic therapy and lysosomal dysfunction for overcoming castration-resistant prostate cancer.Bioact Mater2026https://conductscience.org/library/papers/42165001PubMed
42036664Evolving antibody-drug conjugates in breast cancer from precision delivery to tumor microenvironment reprogramming.J Hematol Oncol2026https://conductscience.org/library/papers/42036664PubMed
40502358Plasma IFN-γ may predict pyrotinib efficacy in patients with HER2-positive advanced breast cancer.Biomed Rep2025https://conductscience.org/library/papers/40502358PubMed
39817135Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature.World J Gastrointest Oncol2025https://conductscience.org/library/papers/39817135PubMed
39766152H1 Antihistamines-Promising Candidates for Repurposing in the Context of the Development of New Therapeutic Approaches to Cancer Treatment.Cancers (Basel)2024https://conductscience.org/library/papers/39766152PubMed
38825147EPA, DHA, and resolvin effects on cancer risk: The underexplored mechanisms.Prostaglandins Other Lipid Mediat2024https://conductscience.org/library/papers/38825147PubMed
37276392Tumor cell-derived spermidine is an oncometabolite that suppresses TCR clustering for intratumoral CD8+ T cell activation.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37276392PubMed
36746936Regulation of immunological tolerance by the p53-inhibitor iASPP.Cell Death Dis2023https://conductscience.org/library/papers/36746936PubMed
36707233Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade.Gut2023https://conductscience.org/library/papers/36707233PubMed
35675434Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression.Sci Transl Med2022https://conductscience.org/library/papers/35675434PubMed
35440553Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.Nat Commun2022https://conductscience.org/library/papers/35440553PubMed
32228703Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer.Mol Cancer2020https://conductscience.org/library/papers/32228703PubMed
31868112Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy.Nanomedicine (Lond)2020https://conductscience.org/library/papers/31868112PubMed
31315034Inflammation and Cancer: Triggers, Mechanisms, and Consequences.Immunity2019https://conductscience.org/library/papers/31315034PubMed
29484440Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review).Int J Oncol2018https://conductscience.org/library/papers/29484440PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28480899

GET https://conductscience.org/api/papers/v1/28480899/authors